Which ‘AI scientist’ suits your lab? A guide for the perplexed
Summary:
A new generation of AI scientists including Claude Science, Co-Scientist, and Biomni is transforming research workflows by accelerating analysis, hypothesis generation, and discovery, while highlighting the continuing importance of human expertise, validation, and scientific judgment.
Biotech startup funding gap widens despite rebound in VC investment
Summary:
Biotech funding rebounded in 2026, but investment increasingly favored later-stage companies, widening the funding gap for seed-stage startups and emerging therapeutic platforms.
AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse
Summary:
AstraZeneca’s late-stage Wainua trial failed in ATTR cardiomyopathy, raising concerns over management credibility while strengthening competitors’ positions in the market.
Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer
Summary:
Agenus discontinued its phase 3 metastatic colorectal cancer trial to concentrate resources on MSS colon cancer, aiming to unlock immunotherapy benefits in this historically resistant disease setting.
ARPA-H awards up to $160M to scientists developing custom genetic medicines
Summary:
ARPA-H will invest up to $160 million to accelerate personalized genetic medicines, supporting custom therapies and umbrella trials for rare pediatric diseases.
